Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

The nonerythropoietic asi… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin.

Artikel i vetenskaplig tidskrift
Författare Xiaoyang Wang
Changlian Zhu
Xinhua Wang
Jens Gammeltoft Gerwien
Andre Schrattenholz
Mats Sandberg
Marcel Leist
Klas Blomgren
Publicerad i Journal of neurochemistry
Volym 91
Nummer/häfte 4
Sidor 900-10
ISSN 0022-3042
Publiceringsår 2004
Publicerad vid Institutionen för fysiologi och farmakologi, Avdelningen för medicinsk fysik
Institutionen för kvinnors och barns hälsa, Avdelningen för pediatrik
Institutionen för fysiologi och farmakologi, Avdelningen för fysiologi
Sidor 900-10
Språk en
Länkar dx.doi.org/10.1111/j.1471-4159.2004...
Ämnesord Animals, Animals, Newborn, Asialoglycoproteins, biosynthesis, blood, pharmacokinetics, therapeutic use, Brain Infarction, pathology, prevention & control, Disease Models, Animal, Erythropoietin, analogs & derivatives, biosynthesis, blood, pharmacokinetics, therapeutic use, Female, Hypoxia-Ischemia, Brain, drug therapy, pathology, Male, Membrane Proteins, metabolism, Nerve Tissue Proteins, metabolism, Proteomics, methods, Rats, Rats, Wistar, Signal Transduction, drug effects, Synaptosomal-Associated Protein 25, Treatment Outcome
Ämneskategorier Medicin och Hälsovetenskap

Sammanfattning

Recently, erythropoietin (EPO) and the nonerythropoietic derivative asialoEPO have been linked to tissue protection in the nervous system. In this study, we tested their effects in a model of neonatal hypoxia-ischemia (HI) in 7-day-old rats (unilateral carotid ligation and exposure to 7.7% O(2) for 50 min). EPO (10 U/g body weight = 80 ng/g; n = 24), asialoEPO (80 ng/g; n = 23) or vehicle (phosphate-buffered saline with 0.1% human serum albumin; n = 24) was injected intraperitoneally 4 h before HI. Both drugs were protective, as judged by measuring the infarct volumes, neuropathological score and gross morphological score. The infarct volumes were significantly reduced by both EPO (52%) and asialoEPO (55%) treatment, even though the plasma levels of asialoEPO had dropped below the detection limit (1 pm) at the onset of HI, while those of EPO were in the nanomolar range. Thus, a brief trigger by asialoEPO before the insult appears to be sufficient for protection. Proteomics analysis after asialoEPO treatment alone (no HI) revealed at least one differentially up-regulated protein, synaptosome-associated protein of 25 kDa (SNAP-25). Activation (phosphorylation) of ERK was significantly reduced in asialoEPO-treated animals after HI. EPO and the nonerythropoietic asialoEPO both provided significant and equal neuroprotection when administered 4 h prior to HI in 7-day-old rats. The protection might be related to reduced ERK activation and up-regulation of SNAP-25.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?